An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT

Por Schaft, Niels, Coccoris, Miriam, Drexhage, Joost, Knoop, Christiaan, de Vries, I. Jolanda M., Adema, Gosse J., Debets, Reno
Publicado em 2013

Recurrence of Melanoma Following T Cell Treatment: Continued Antigen Expression in a Tumor That Evades T Cell Recruitment

Por Straetemans, Trudy, Berrevoets, Cor, Coccoris, Miriam, Treffers-Westerlaken, Elike, Wijers, Rebecca, Cole, David K, Dardalhon, Valerie, Sewell, Andrew K, Taylor, Naomi, Verweij, Jaap, Debets, Reno
Publicado no Mol Ther (2015)

TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation

Por de Witte, Moniek A., Bendle, Gavin M., van den Boom, Marly D., Coccoris, Miriam, Schell, Todd D., Tevethia, Satvir S., van Tinteren, Harm, Mesman, Elly M., Song, Ji-Ying, Schumacher, Ton N.M.
Publicado em 2008